United States
Germany
Japan
United Kingdom
China
ATP6V1D (Myc-DDK-tagged)-Human ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (ATP6V1D)
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pCMV6-Entry |
- TrueORF®
Products
ATP6V1D (tGFP-tagged) - Human ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (ATP6V1D)
| Type | Human Tagged ORF Clone |
| Tag | TurboGFP |
| Vector | pCMV6-AC-GFP |
- TrueORF®
ATP6V1D - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
Lenti ORF clone of Human ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (ATP6V1D), mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP-P2A-Puro |
- LentiORF®
ATP6V1D CRISPRa kit - CRISPR gene activation of human ATPase H+ transporting V1 subunit D
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Lenti ORF clone of Human ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (ATP6V1D), Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
ATP6V1D (untagged)-Human ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D (ATP6V1D)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL5 |
ATP6V1D - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
ATP6V1D - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
| Format | Retroviral plasmids |
| Vector | pRS |
3' UTR clone of ATPase H+ transporting lysosomal 34kDa V1 subunit D (ATP6V1D) for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
qSTAR qPCR primer pairs against Homo sapiens gene ATP6V1D
ATP6V1D (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
